WSES 重症急性胰腺炎管理指南(2019)解读

2019-09-30 中国普通外科杂志.2019.28(9):1048-1053.

近年来重症急性胰腺炎的研究取得了一些进展,对临床的诊治有较为明显的影响。2018 年在意大利贝蒂诺罗举行的世界急诊外科大会上,专家协作小组基于循证提出了重症急性胰腺炎管理的国际共识(使用GRADE 证据质量分级),并于2019 年6 月发表于世界急诊外科杂志。该指南主要包括以下5 个主题:重症急性胰腺炎的诊断、抗生素治疗、重症监护室的管理、外科及手术处理和腹腔开放,全面地总结概括了重症急性胰腺炎的

中文标题:

WSES 重症急性胰腺炎管理指南(2019)解读

发布机构:

发布日期:

2019-09-30

简要介绍:

近年来重症急性胰腺炎的研究取得了一些进展,对临床的诊治有较为明显的影响。2018 年在意大利贝蒂诺罗举行的世界急诊外科大会上,专家协作小组基于循证提出了重症急性胰腺炎管理的国际共识(使用GRADE 证据质量分级),并于2019 年6 月发表于世界急诊外科杂志。该指南主要包括以下5 个主题:重症急性胰腺炎的诊断、抗生素治疗、重症监护室的管理、外科及手术处理和腹腔开放,全面地总结概括了重症急性胰腺炎的临床诊治原则,反映了当前重症急性胰腺炎的治疗现状和进展,值得参考、学习和借鉴。

作者:中南大学湘雅医院胰胆外科 朱帅 黄耿文 

拓展指南:胰腺炎相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=WSES 重症急性胰腺炎管理指南(2019)解读)] GetToolGuiderByIdResponse(projectId=1, id=ac82e1c001805e6f, title=WSES 重症急性胰腺炎管理指南(2019)解读, enTitle=, guiderFrom=中国普通外科杂志.2019.28(9):1048-1053., authorId=null, author=, summary=近年来重症急性胰腺炎的研究取得了一些进展,对临床的诊治有较为明显的影响。2018 年在意大利贝蒂诺罗举行的世界急诊外科大会上,专家协作小组基于循证提出了重症急性胰腺炎管理的国际共识(使用GRADE 证据质量分级),并于2019 年6 月发表于世界急诊外科杂志。该指南主要包括以下5 个主题:重症急性胰腺炎的诊断、抗生素治疗、重症监护室的管理、外科及手术处理和腹腔开放,全面地总结概括了重症急性胰腺炎的, cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Mon Sep 30 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>近年来重症急性胰腺炎的研究取得了一些进展,对临床的诊治有较为明显的影响。2018 年在意大利贝蒂诺罗举行的世界急诊外科大会上,专家协作小组基于循证提出了重症急性胰腺炎管理的国际共识(使用GRADE 证据质量分级),并于2019 年6 月发表于世界急诊外科杂志。该指南主要包括以下5 个主题:重症急性胰腺炎的诊断、抗生素治疗、重症监护室的管理、外科及手术处理和腹腔开放,全面地总结概括了重症急性胰腺炎的临床诊治原则,反映了当前重症急性胰腺炎的治疗现状和进展,值得参考、学习和借鉴。 </P> <P>作者:中南大学湘雅医院胰胆外科 朱帅 黄耿文 </P>拓展指南:<STRONG>与<FONT color=red>胰腺炎</FONT>相关指南:</STRONG><BR> <UL> <LI><A title="2019 WSES指南:急性重症胰腺炎的管理" target=_blank href="https://www.medsci.cn/guideline/show_article.do?id=7fe7e1c001e52761">2019 WSES指南:急性重症胰腺炎的管理</A> <LI><A title="2018 ESGE指南:慢性胰腺炎的内镜治疗" target=_blank href="https://www.medsci.cn/guideline/show_article.do?id=eb3621c0016931c4">2018 ESGE指南:慢性胰腺炎的内镜治疗</A> <LI><A title="2018 IAP/APA/JPS/EPC指南:慢性胰腺炎截面影像学诊断和严重程度评分" target=_blank href="https://www.medsci.cn/guideline/show_article.do?id=86d0d1c001638313">2018 IAP/APA/JPS/EPC指南:慢性胰腺炎截面影像学诊断和严重程度评分</A> <LI><A title="2018 NICE指南:胰腺炎(NG.104)" target=_blank href="https://www.medsci.cn/guideline/show_article.do?id=554e41c00163e59d">2018 NICE指南:胰腺炎(NG.104)</A> <LI><A title="2018 儿童时期自身免疫性胰腺炎的诊断和管理建议" target=_blank href="https://www.medsci.cn/guideline/show_article.do?id=5c0b21c001629585">2018 儿童时期自身免疫性胰腺炎的诊断和管理建议</A> 更多信息请点击:<A target=_blank href="https://www.medsci.cn/guideline/list.do?q=%E8%83%B0%E8%85%BA%E7%82%8E">有关胰腺炎更多指南</A></LI></UL>, tagList=[TagDto(tagId=91444, tagName=急性重症胰腺炎)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=12876, appHits=1533, showAppHits=13, pcHits=4762, showPcHits=8449, likes=92, shares=63, comments=14, approvalStatus=1, publishedTime=Sat Oct 19 21:46:48 CST 2019, publishedTimeString=2019-09-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Oct 19 21:46:48 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 15:24:51 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=WSES 重症急性胰腺炎管理指南(2019)解读)])
WSES 重症急性胰腺炎管理指南(2019)解读
下载请点击:
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=960571, encodeId=c07d9605e147, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/f6ec0ca6c7e849a18869167cd0e3c9b1/003cba24eefc40e094965ae4d343c573.jpg, createdBy=258d5150395, createdName=14695912m98暂无昵称, createdTime=Mon Apr 26 10:55:44 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926287, encodeId=7df992628e89, content=感谢作者, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96d65461926, createdName=ms3000000566380224, createdTime=Mon Feb 22 09:28:32 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911850, encodeId=611f9118509a, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200908/5b0ff68245eb414e90c2f559e24ae889/aee400ffe9a94cf9b05aab182a3a4f86.jpg, createdBy=5a1f5251943, createdName=急诊小张, createdTime=Tue Dec 29 10:06:29 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903308, encodeId=cdfb903308ac, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f972413425, createdName=1237f264m62(暂无昵称), createdTime=Sun Nov 29 16:25:12 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900785, encodeId=f99d900e85b0, content=感谢作者, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ5Nfq0OSb9yM9v8vsHM3dzCNpOW8pY83RGlV1E4hVh6AuBicPkxAA2a3oMXmqGXsbhAXgApnicwOkg/0, createdBy=97b42235401, createdName=lolaloha, createdTime=Fri Nov 20 14:25:10 CST 2020, time=2020-11-20, status=1, ipAttribution=)]
    2021-04-26 14695912m98暂无昵称

    不错

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=960571, encodeId=c07d9605e147, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/f6ec0ca6c7e849a18869167cd0e3c9b1/003cba24eefc40e094965ae4d343c573.jpg, createdBy=258d5150395, createdName=14695912m98暂无昵称, createdTime=Mon Apr 26 10:55:44 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926287, encodeId=7df992628e89, content=感谢作者, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96d65461926, createdName=ms3000000566380224, createdTime=Mon Feb 22 09:28:32 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911850, encodeId=611f9118509a, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200908/5b0ff68245eb414e90c2f559e24ae889/aee400ffe9a94cf9b05aab182a3a4f86.jpg, createdBy=5a1f5251943, createdName=急诊小张, createdTime=Tue Dec 29 10:06:29 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903308, encodeId=cdfb903308ac, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f972413425, createdName=1237f264m62(暂无昵称), createdTime=Sun Nov 29 16:25:12 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900785, encodeId=f99d900e85b0, content=感谢作者, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ5Nfq0OSb9yM9v8vsHM3dzCNpOW8pY83RGlV1E4hVh6AuBicPkxAA2a3oMXmqGXsbhAXgApnicwOkg/0, createdBy=97b42235401, createdName=lolaloha, createdTime=Fri Nov 20 14:25:10 CST 2020, time=2020-11-20, status=1, ipAttribution=)]
    2021-02-22 ms3000000566380224

    感谢作者

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=960571, encodeId=c07d9605e147, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/f6ec0ca6c7e849a18869167cd0e3c9b1/003cba24eefc40e094965ae4d343c573.jpg, createdBy=258d5150395, createdName=14695912m98暂无昵称, createdTime=Mon Apr 26 10:55:44 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926287, encodeId=7df992628e89, content=感谢作者, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96d65461926, createdName=ms3000000566380224, createdTime=Mon Feb 22 09:28:32 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911850, encodeId=611f9118509a, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200908/5b0ff68245eb414e90c2f559e24ae889/aee400ffe9a94cf9b05aab182a3a4f86.jpg, createdBy=5a1f5251943, createdName=急诊小张, createdTime=Tue Dec 29 10:06:29 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903308, encodeId=cdfb903308ac, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f972413425, createdName=1237f264m62(暂无昵称), createdTime=Sun Nov 29 16:25:12 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900785, encodeId=f99d900e85b0, content=感谢作者, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ5Nfq0OSb9yM9v8vsHM3dzCNpOW8pY83RGlV1E4hVh6AuBicPkxAA2a3oMXmqGXsbhAXgApnicwOkg/0, createdBy=97b42235401, createdName=lolaloha, createdTime=Fri Nov 20 14:25:10 CST 2020, time=2020-11-20, status=1, ipAttribution=)]
    2020-12-29 急诊小张

    优秀

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=960571, encodeId=c07d9605e147, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/f6ec0ca6c7e849a18869167cd0e3c9b1/003cba24eefc40e094965ae4d343c573.jpg, createdBy=258d5150395, createdName=14695912m98暂无昵称, createdTime=Mon Apr 26 10:55:44 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926287, encodeId=7df992628e89, content=感谢作者, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96d65461926, createdName=ms3000000566380224, createdTime=Mon Feb 22 09:28:32 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911850, encodeId=611f9118509a, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200908/5b0ff68245eb414e90c2f559e24ae889/aee400ffe9a94cf9b05aab182a3a4f86.jpg, createdBy=5a1f5251943, createdName=急诊小张, createdTime=Tue Dec 29 10:06:29 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903308, encodeId=cdfb903308ac, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f972413425, createdName=1237f264m62(暂无昵称), createdTime=Sun Nov 29 16:25:12 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900785, encodeId=f99d900e85b0, content=感谢作者, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ5Nfq0OSb9yM9v8vsHM3dzCNpOW8pY83RGlV1E4hVh6AuBicPkxAA2a3oMXmqGXsbhAXgApnicwOkg/0, createdBy=97b42235401, createdName=lolaloha, createdTime=Fri Nov 20 14:25:10 CST 2020, time=2020-11-20, status=1, ipAttribution=)]
    2020-11-29 1237f264m62(暂无昵称)

    不错

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=960571, encodeId=c07d9605e147, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/f6ec0ca6c7e849a18869167cd0e3c9b1/003cba24eefc40e094965ae4d343c573.jpg, createdBy=258d5150395, createdName=14695912m98暂无昵称, createdTime=Mon Apr 26 10:55:44 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926287, encodeId=7df992628e89, content=感谢作者, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96d65461926, createdName=ms3000000566380224, createdTime=Mon Feb 22 09:28:32 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911850, encodeId=611f9118509a, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200908/5b0ff68245eb414e90c2f559e24ae889/aee400ffe9a94cf9b05aab182a3a4f86.jpg, createdBy=5a1f5251943, createdName=急诊小张, createdTime=Tue Dec 29 10:06:29 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903308, encodeId=cdfb903308ac, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f972413425, createdName=1237f264m62(暂无昵称), createdTime=Sun Nov 29 16:25:12 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900785, encodeId=f99d900e85b0, content=感谢作者, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ5Nfq0OSb9yM9v8vsHM3dzCNpOW8pY83RGlV1E4hVh6AuBicPkxAA2a3oMXmqGXsbhAXgApnicwOkg/0, createdBy=97b42235401, createdName=lolaloha, createdTime=Fri Nov 20 14:25:10 CST 2020, time=2020-11-20, status=1, ipAttribution=)]
    2020-11-20 lolaloha

    感谢作者

    0